Datwyler Launches RFS Combiseals for Cartridges
These components take the burden off drug manufacturers to prep packaging components for sterilization, while helping to enhance the drug filling and packaging process.
Datwyler, a provider of elastomer components, has launched its ready-for-sterilization (RFS) combiseals for cartridges, which are used in injection devices such as pens and autoinjectors. As combiseals are in direct contact with the drugs administered, they must be clean enough to comply with regulatory requirements and prevent any risk to patients.
Before arriving at the sterile drug manufacturer, the RFS combiseals undergo Datwyler’s own Water-for-Injection washing process and are packed in steam sterilizable (RFS) bags to ensure a controlled state of microbiological cleanliness that complies with FDA and EU requirements. This allows for immediate sterilization of the combiseals.
“In general, there is a trend that pharma companies want to focus mainly on their core activities: drug manufacturing. Washing and sterilization of rubber materials is more and more done by the rubber manufacturers,” says Carina Van Eester, global platform leader, prefilled syringes and cartridges, Datwyler. “Combiseals are the final product in our portfolio to supply in RFS format. Bringing value for our customers has always been a guiding force behind Datwyler’s overall philosophy.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
